Laborie, an international leader in medical devices but notably gastroenterology, has signed an OEM agreement with Bedfont Scientific for its Gastrolyzer range of hydrogen and methane breath monitors.
The Gastrolyzer range offers a quicker, more efficient, and non-invasive method to investigating and detecting gastrointestinal disorders compared to more traditional methods which can take up to two weeks to diagnose and require a blood sample.
Albert Meek, Laborie general manager, GI Solutions, comments: “Breath analysis is such an innovative leap in medical technology, saving specialists and patients’ time and hassle. The Gastrolyzer range of high-quality hydrogen and methane breath monitors will enable us to further deliver Gastroenterological solutions that advance diagnostic confidence and transform the treatment of care.”
This major OEM deal comes shortly after Bedfont recently signed another OEM deal with Global Medicare for the Gastrolyzer range exclusively in India.
Jason Smith, general manager at Bedfont Scientific, says: “These OEMs are part of our expansion plan for our core breath business. The aim is to make breath analysis global and easily accessible, allowing more people to be diagnosed by a faster, more efficient and non-invasive method. Thanks to Laborie, breath analysis will now be available in medical markets worldwide that Bedfont did not have access to before.”
